| scholarly article | Q13442814 |
| P50 | author | Christopher Linington | Q41652456 |
| Pandelakis A. Koni | Q42588019 | ||
| Chelsea R Parker Harp | Q49336637 | ||
| Stephen T Ferris | Q57132789 | ||
| P2093 | author name string | Gregory F Wu | |
| John H Russell | |||
| Michiko Shimoda | |||
| Julia Sim | |||
| Angela S Archambault | |||
| Robert J Mikesell | |||
| P2860 | cites work | Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases | Q81594596 |
| B-cell depletion with rituximab in relapsing-remitting multiple sclerosis | Q28268626 | ||
| CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity | Q28589339 | ||
| Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis | Q33702321 | ||
| Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid | Q33745475 | ||
| Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology | Q34048094 | ||
| Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. | Q34052870 | ||
| The role of antigen presenting cells in multiple sclerosis | Q34268029 | ||
| Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity. | Q34645411 | ||
| IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases | Q34658996 | ||
| Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression | Q34831296 | ||
| Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. | Q35009513 | ||
| Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice | Q35009518 | ||
| Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders | Q35544312 | ||
| Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients | Q35585366 | ||
| Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. | Q35769109 | ||
| Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein | Q35891689 | ||
| B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells | Q35946128 | ||
| B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity | Q36034499 | ||
| Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter | Q36117107 | ||
| Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity | Q36171818 | ||
| Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation | Q36174679 | ||
| Multiple sclerosis--the plaque and its pathogenesis | Q36410882 | ||
| Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. | Q36506367 | ||
| Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis | Q37031308 | ||
| Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS | Q37258223 | ||
| Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. | Q37273211 | ||
| MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies | Q37397820 | ||
| The role of antibodies in multiple sclerosis | Q37769908 | ||
| The immunopathophysiology of multiple sclerosis | Q37857982 | ||
| Cutting edge: Conditional MHC class II expression reveals a limited role for B cell antigen presentation in primary and secondary CD4 T cell responses | Q39138822 | ||
| APCs present A beta(k)-derived peptides that are autoantigenic to type B T cells. | Q40656630 | ||
| B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice | Q41028078 | ||
| Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial | Q42647640 | ||
| Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice | Q44484576 | ||
| Experimental autoimmune encephalomyelitis repressed by microglial paralysis. | Q45235066 | ||
| Active induction of experimental allergic encephalomyelitis | Q48175463 | ||
| The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles | Q48914128 | ||
| Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma | Q48971811 | ||
| Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. | Q50515193 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Role of MHC class II on memory B cells in post-germinal center B cell homeostasis and memory response. | Q51985051 | ||
| Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. | Q53846430 | ||
| De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. | Q53974447 | ||
| Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? | Q57041523 | ||
| Dendritic Cells Ameliorate Autoimmunity in the CNS by Controlling the Homeostasis of PD-1 Receptor+ Regulatory T Cells | Q58621017 | ||
| Antigen-specific interaction between T and B cells | Q59063745 | ||
| Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions | Q59070288 | ||
| Evidence for pathogenic heterogeneity in multiple sclerosis | Q61709616 | ||
| A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease | Q68834759 | ||
| Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein | Q74456215 | ||
| Experimental autoimmune encephalomyelitis (EAE) | Q81130780 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| neuronitis | Q17157137 | ||
| P304 | page(s) | 5077-5084 | |
| P577 | publication date | 2015-04-20 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis | |
| P478 | volume | 194 |
| Q40530656 | Activated GL7+ B cells are maintained within the inflamed CNS in the absence of follicle formation during viral encephalomyelitis. |
| Q39594953 | Amelioration of EAE by a cryptic epitope of myelin oligodendrocyte glycoprotein. |
| Q58560818 | Antigen-presenting cell diversity for T cell reactivation in central nervous system autoimmunity |
| Q36742838 | Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. |
| Q30248983 | Autoimmunity in 2015. |
| Q92249491 | B Cell-Mediated Antigen Presentation through MHC Class II Is Dispensable for Atherosclerosis Progression |
| Q26770664 | B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions |
| Q95840980 | B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers |
| Q55512364 | B cells are capable of independently eliciting rapid reactivation of encephalitogenic CD4 T cells in a murine model of multiple sclerosis. |
| Q91236273 | B cells in autoimmune and neurodegenerative central nervous system diseases |
| Q36788638 | CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis |
| Q92884441 | Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients |
| Q64279716 | Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis |
| Q57810320 | Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis |
| Q39509470 | Increased ex vivo antigen presentation profile of B cells in multiple sclerosis |
| Q26779416 | Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation |
| Q38684427 | Influenza infection triggers disease in a genetic model of experimental autoimmune encephalomyelitis |
| Q59126360 | Innate and adaptive signals enhance differentiation and expansion of dual-antibody autoreactive B cells in lupus |
| Q63363253 | Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE |
| Q39188128 | Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies |
| Q49315731 | Murine splenic B cells express corticotropin-releasing hormone receptor 2 that affect their viability during a stress response |
| Q33645795 | Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases. |
| Q37014400 | Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen. |
| Q90471432 | Novel B cell-dependent multiple sclerosis model using extracellular domains of myelin proteolipid protein |
| Q38665518 | Ocrelizumab: a B-cell depleting therapy for multiple sclerosis |
| Q26743398 | Positive and negative functions of B lymphocytes in tumors |
| Q52657141 | Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation. |
| Q64082934 | The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to imaging |
| Q96171695 | Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica |
Search more.